7FTX | pdb_00007ftx

Crystal Structure of apo human cyclic GMP-AMP synthase - hexagonal form


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.83 Å
  • R-Value Free: 
    0.278 (Depositor), 0.226 (DCC) 
  • R-Value Work: 
    0.243 (Depositor) 
  • R-Value Observed: 
    0.245 (Depositor) 

Starting Model: other
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7FTX

This is version 1.1 of the entry. See complete history

Literature

Crystal Structure of a human cyclic GMP-AMP synthase complex

Groebke-Zbinden, K.Vandemeulebroucke, A.Hilbert, M.Rudolph, M.G.

To be published.

Macromolecule Content 

  • Total Structure Weight: 43.08 kDa 
  • Atom Count: 2,954 
  • Modeled Residue Count: 356 
  • Deposited Residue Count: 363 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Cyclic GMP-AMP synthase363Homo sapiensMutation(s): 0 
Gene Names: CGASC6orf150MB21D1
EC: 2.7.7.86
UniProt & NIH Common Fund Data Resources
Find proteins for Q8N884 (Homo sapiens)
Explore Q8N884 
Go to UniProtKB:  Q8N884
PHAROS:  Q8N884
GTEx:  ENSG00000164430 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ8N884
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.83 Å
  • R-Value Free:  0.278 (Depositor), 0.226 (DCC) 
  • R-Value Work:  0.243 (Depositor) 
  • R-Value Observed: 0.245 (Depositor) 
Space Group: P 61 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 101.235α = 90
b = 101.235β = 90
c = 240.332γ = 120
Software Package:
Software NamePurpose
XSCALEdata scaling
BUSTERrefinement
PDB_EXTRACTdata extraction
XDSdata reduction
XSCALEdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
F. Hoffmann-La Roche LTDSwitzerland--

Revision History  (Full details and data files)

  • Version 1.0: 2024-02-21
    Type: Initial release
  • Version 1.1: 2026-02-18
    Changes: Refinement description, Structure summary